论文部分内容阅读
目的观察联合检验尿糖与尿微量白蛋白在糖尿病早期肾损伤诊断中的临床意义。方法选取2015年9月-2016年8月期间,东丽医院内分泌科收治的糖尿病患者80例作为观察组,再选择同期于东丽医院体检的健康人群80例作为对照组,观察组及对照组均检验尿糖与尿微量白蛋白,观察两组人群尿糖及尿微量白蛋白检验结果区别。结果观察组尿微量白蛋白、尿糖分别为(22.46±4.16)mg/L和(2.32±0.68)mmol/L,高于对照组的(15.24±4.17)mg/L和(2.03±0.55)mmol/L,差异均有统计学意义(P<0.05);观察组尿微量白蛋白阳性率、尿糖阳性率分别为78.75%和33.75%,高于对照组的0.00%和0.00%,差异均有统计学意义(P<0.05)。结论联合检验尿糖与尿微量白蛋白,可显著提高糖尿病早期肾损伤诊断的准确性与可信度。
Objective To observe the clinical significance of urine test and urine microalbumin in the diagnosis of early diabetic nephropathy. Methods Eighty diabetic patients admitted to Department of Endocrinology of Toray Hospital were selected as the observation group from September 2015 to August 2016. Eighty healthy people in the same period of physical examination at Toray Hospital were selected as control group, observation group and control group Urine and urine microalbumin were tested, urine and urine microalbumin test results were observed between the two groups. Results The urinary albumin and urinary glucose in the observation group were (22.46 ± 4.16) mg / L and (2.32 ± 0.68) mmol / L, respectively, higher than those in the control group (15.24 ± 4.17 and 2.03 ± 0.55 mmol / / L, the differences were statistically significant (P <0.05); the positive rate of urine microalbuminuria and urine glucose in the observation group were 78.75% and 33.75% respectively, which were higher than those in the control group (0.00% and 0.00%, respectively) Statistical significance (P <0.05). Conclusion The combined testing of urinary glucose and urine microalbumin can significantly improve the accuracy and reliability of the diagnosis of diabetic nephropathy.